3 results
Primary: To demonstrate the superior efficacy of Nasalfent in the treatment of BTCP in opioid tolerant subjects who are receiving regular opioid therapy.Secondary: To demonstrate the safety, tolerability, and acceptability of Nasalfent in the…
1. To study the differential effectiveness of three cueing modalities on gait parameters, gait stability, and interlimb coordination in people with Parkinson's disease 2. To study the differences between self-selected and a 10% increased cueing…
The main study endpoint will be the mean preoperative morphine use per hour in patients with and without FICB with levobupivacaine, guided by ultrasound. Secondary parameters will include the pain scores reported by the numerical rating scale both…